Completed NA INTERVENTIONAL 2-arm NCT06402032

Clinical and Histological Evaluation of Hesperidin as a Direct Pulp Capping Material

Clinical and Histological Evaluation of Hesperidin Versus Mineral Trioxide Aggregate (MTA) as a Direct Pulp Capping Material: A Randomized Controlled Trial

Sponsor: Cairo University

Conditions Dental Pulp Capping Pulp Exposure, Dental

Interventions Hesperidin Mineral Trioxide Aggregate (MTA)

Updated 3 times since 2024 Last updated: May 3, 2024 Started: Sep 1, 2022 Primary completion: Dec 1, 2023 Completion: Mar 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06402032, this NA trial focuses on Dental Pulp Capping and Pulp Exposure, Dental and remains completed. Sponsored by Cairo University, it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2024 — Jul 2024 [monthly]

Completed NA

First recorded

Sep 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt